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Abstract
Background: Kenya has experienced a number of retail sector initiatives aimed at improving access to antimalarial
medicines. This study explored stakeholders’ perceptions of the role of private medicine retailers (PMRs), the value
and feasibility of programme goals, perceived programme impact, factors influencing implementation and
recommendations in three districts of Kenya.
Methods: This study was part of a larger evaluation of PMR programmes, including quantitative and qualitative
components. The qualitative research was conducted to assess implementation processes and actors’ experiences
in the programmes, through focus group discussions with trained PMRs and mothers of children under five years,
and in-depth interviews with programme managers, trainers and co-trainers.
Results: PMRs were perceived to provide rapid cheap treatment for non-serious conditions and used as a
deliberate and continuously evaluated choice between different treatment sources. All stakeholders supported
programme goals and most PMRs described increased customer satisfaction, more rational purchasing of medicine
stock and increased medicine sales after participation. Factors undermining programme implementation included a
lack of MoH resources to train and monitor large numbers of PMRs, the relative instability of outlets, medicines
stocked and retail personnel, the large number of proprietary brands and financial challenges to retailers in
stocking antimalarial medicines, and their customers in buying them. Unambiguous national support and a broad
range of strategies are important to strengthen the feasibility of change in OTC antimalarial use.
Conclusions: Understanding the context and implementation processes of PMR programmes and the perspectives
of key actors are critical to identifying measures to support their effective implementation. Financial barriers
underlie many described challenges, with important implications for policies on subsidies in this sector. In spite of
barriers to implementation, increased exposure to programme activities promoted trust and improved relationships
between PMRs and their clients and trainers, strengthening feasibility of such interventions. Public information can
strengthen PMR training programmes by engaging local communities and may facilitate performance monitoring
of PMRs by their clients.
Background
The rationale for encouraging effective home use of
antimalarial drugs as a strategy for malaria control is
based on an understanding of the importance of self
medication, including the popularity of this practice, the
role of private medicines retailers (PMRs) in providing
medicines used at home, and the inappropriate
treatment practices often involved [1-4]. The prompt-
ness of self medication practices alongside objectives
that childhood fevers are presumptively treated as
malaria within 24 hours of onset of illness [5-7] have
highlighted the potential role that PMRs could play in
malaria control strategies. Whilst concerns exist about
regulation of activities in the retail sector, the pragmatic
approach of channeling information on Over-The-Coun-
ter (OTC) medicines through PMRs has the potential to
improve the early treatment of childhood fevers, and
may have cost and sustainability advantages over other
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settings including Kenya where PMRs are licensed to
sell OTC medicines such as analgesics, antipyretics, pro-
prietary antimalarial medicines. Although in practice
some PMRs include other prescription only medicines
in their stock [12,13].
In recent years, Kenya has experienced several private
sector initiatives aimed at improving access to antima-
larial medicines through the retail sector. The retail
sector initiatives in Kenya were based on participatory
training of PMRs with public information, and social
marketing and social franchising approaches [9,14-16].
The 2001 Kenya National Malaria Strategy recom-
mended such programmes as a means of improving
early access to effective antimalarial treatment for chil-
dren with fever [17]. Between 2002 and 2005, the Divi-
sion of Malaria Control (DOMC) in the Ministry of
Health (MoH) supported over 30 districts to obtain
funding through the Global Fund for AIDS, TB and
Malaria (GFATM) to implement PMR programmes. On
the basis of DOMC implementation guidelines [18],
a research team from the Kenya Medical Research Insti-
tute (KEMRI)-Wellcome Trust Programme worked in
collaboration with the DOMC and District Health Man-
agement Teams (DHMTs) in Busia, Kwale and Makueni
districts to support implementation and evaluate the
PMR programmes implemented.
The current evidence on the impact of the retail
sector interventions is largely quantitative [19]. Whereas
this evidence is important in understanding the potential
role of the retail sector in improving access to antima-
larial medicines, it does not provide insights on the
dynamics of implementation, actors’ perceptions about
their role, and the challenges experienced in implement-
ing and practising the intervention. Theory and empiri-
cal work around policy considers the importance of
implementation processes and their implications for pol-
icy achievements. Going beyond conventional public
health understandings, the policy literature sees the
implementation process as full of contestation, negotia-
tion and bargaining among implementing actors (indivi-
duals and organisations), leading to decisions that shape
the implementation [20]. The bulk of the current evi-
dence describes the technical content of policy rather
than the implementation process and the context in
which decisions are made [21].
To address this knowledge gap, this evaluation incor-
porated qualitative as well as quantitative methods to
provide an understanding of the overall effectiveness of
MoH PMR interventions in three districts and the fac-
tors that influenced this. Findings of the quantitative
component have been reported elsewhere [22] and show
that the MoH programmes led to a major improvement
in PMR practices with a significantly higher proportion
of intervention PMRs selling amodiaquine (AQ) medi-
cines with accurate information on its use. There was
also an impact on PMR knowledge with more interven-
tion PMRs knowing how to use AQ medicines than
those from control areas. This paper aims to describe
factors influencing implementation of the PMR
programmes in three districts, based on an analysis of
qualitative findings.
Programme Implementation
The programme was coordinated by the DOMC as the
lead agency providing technical support for implementa-
tion. District Public Health Officers (Officer in charge of
control of communicable diseases and general sanitation
in the district) together with other district health man-
agers coordinated the programme at the district level.
At the divisional level (the fourth administrative tier in
Kenya), the Public Health Officers (PHO) were the main
trainers. These are officers with two or three years of
tertiary level training on the control of communicable
diseases in the community and have normal responsibil-
ity for regulating the sales of food and medicines in the
community, provide licenses to operate, and assess qual-
ity through inspecting expiry dates, physical appearances
and storage conditions. They were supported by com-
munity volunteers, who were selected, either by local
chiefs or local communities, from the general commu-
nity as co-trainers. Co-trainers undertook retailer
recruitment, facilitated setting up training venues and
conducted public information and monitoring activities
alongside MoH trainers.
The core elements of the programmes implemented in
all three districts included a five day training of core
management personnel; recruitment and training work-
shops for selected PMRs; development, production and
dissemination of information, education and communi-
cation materials; public information activities; training of
PMRs; and monitoring and supervision activities. Selec-
tion of PMRs included all of the following criteria; being
the main seller (where more than one seller was present
in an outlet); working in an outlet with current stocks
of antimalarial medicines; being located in a rural set-
ting; and considered as relatively stable on the basis of
local PHO knowledge. PMRs were trained in skill-based
workshops by PHOs assisted by community volunteers
as co-trainers.
PMRs were invited to a central place in the local set-
tings during normal working hours for a two-day parti-
cipatory workshop with each workshop having at least
25 participants. The training covered: signs of simple
and severe malaria; malaria treatment and prevention;
drug resistance; referral practices; storage and expiry of
medicines; and communication skills. PMRs were given
approximately $ 3.7 (Based on an exchange rate of
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shops. In Kwale, Busia and Makueni, respectively, 122,
79 and 247 PMRs were reportedly trained in the inter-
vention divisions. In these settings, the number of out-
lets per division varies between 300-400 retail outlets.
Trainings were conducted between December 2004 and
February 2005 and the evaluation was conducted about
six to eight months post implementation.
Public information activities were conducted by PHOs
and co-trainers through public meetings including those
of local leaders, church congregations and other special
groups, such as women’s groups. Public information
strategies aimed at creating awareness of the aims of the
programme, explaining the roles of PMR and identifying
programme outlets. Trained PMRs were monitored
through regular shop visits by their trainers (either divi-
sional PHOs or co-trainers) with the aim of continuing
education and helping PMRs to solve problems arising
from their new practices.
Materials for the programme were either produced
locally at district level or commercially printed by the
DOMC for distribution to all districts. Locally produced
materials for the programme included two A4 sized
laminated charts for trained PMRs giving dosage
and referral information (Figure 1A). The DOMC
produced a poster to be hung outside outlets to indicate
trained status (Figure 1B), a 24 page booklet for trained
sellers covering the main areas of the workshop (Figure
1C), and a leaflet on the programme for public dissemi-
nation. The model for these programmes was based on
a generic strategy adopted by the DOMC developed
through a series of advocacy meetings by the DOMC
and its partners in 2001[23].
Methods
Study areas
This study was part of a larger evaluation designed as a
cluster randomized trial across three districts with divi-
sions as the units of randomization [22]. The DHMTs
in each district identified divisions they considered simi-
lar in socio-economic characteristics, malaria burden,
malaria control programs and access to health care facil-
ities prior to randomization. In Kwale and Makueni, two
interventions and two controls divisions were selected.
In Busia, one intervention and one control division were
purposively selected. The qualitative component
reported here was conducted in the intervention divi-
sions of Kwale (Matuga and Kinango), Makueni
(Kathonzweni and Makindu) and Busia (Funyula).
Geographically, Busia is located in Western Kenya, with
a population of 405,389. Kwale district lies in Coastal
Kenya with a population of 544, 468. Both districts
experiences year round malaria transmission. Makueni
is located in Eastern Province, with a population of 771,
545. It is a semi-arid district with seasonal malaria
transmission.
Data collection methods
These evaluations were conducted between July and
October 2005, an average of 6 months for Kwale and
Makueni programmes and 8 months for the Busia pro-
gramme after completion of the last training workshop.
Data was collected through focus group discussions
(FGDs) targeting trained PMRs and mothers of chil-
dren under five years of age in the intervention areas.
FGDs covered the role of PMRs in treating fevers,
training activities and materials used, awareness and
support for programme infrastructure and goals, per-
ceptions of feasibility, benefits and disadvantages of
using the retail sector channel, perceived impacts,
recommendations for various programme activities. In
depth interviews (IDIs) targeting programme managers,
trainers, co-trainers were used to elicit information on
their understanding, perspectives and experiences with
the programme. The interviews covered similar issues
addressed in the FGDs with additional areas on imple-
mentation process factors influencing effective
programme outcomes and perceived impacts. Table 1
shows the target groups, methods and number of
respondents included in the study.
Sample selection
Study participants were selected purposively to provide
representative views from different geographic areas
within study sites. Sampling for FGDs endeavoured to
create a homogenous group with similar experiences to
facilitate dialogue [24]. Mothers of children under five
years were invited from homes near trained outlets.
Trained PMRs from rural areas, small and large market
centres were invited to attend discussions. Local admin-
istrative leaders assisted with recruitment. Each FGD
targeted 6-12 participants. For IDIs we aimed to inter-
view all co-trainers, trainers and managers. One research
assistant (YR) conducted most interviews supported by
(TA) while a locally recruited assistant fluent in local
languages took notes. Data was recorded both in written
notes and tape recording. Written notes were used to
provide backup copies and to capture nonverbal cues.
Across all sites an attempt was made to elicit informa-
tion from different categories of actors involved in the
implementation process. In some circumstances a num-
ber of actors had been transferred from the districts
limiting the number of interviews. However, attempts
were made to reach at least all actors available in the
district. All discussions were done in languages under-
standable to the participants and recordings were con-
ducted within the boundaries of confidentiality agreed at
the time of discussions.
Rowa et al. BMC Public Health 2010, 10:93
http://www.biomedcentral.com/1471-2458/10/93
Page 3 of 14Figure 1 Samples of materials used for the retailer training programmes in Kenya: a- is an image of an A4 sized chart for display in retail
outlets showing the dose of the MoH recommended antimalarial medicine according to age; b-is an image of a DoMC produced poster to be
hung outside outlets to indicate trained status; c- an image of a 24 page booklet for trained sellers covering the main areas of the workshop.
Table 1 Target groups, methods used and number of interviews
Category Busia
(Funyula)
Kwale (Kinango) Kwale (Matuga) Makueni (Kathonzweni) Makueni (Makindu) Total
Mothers FGDs 4 2 2 2 3 13
Trained sellers FGDs 1 2 1 3 3 10
Trained sellers IDIs 3 - 1 - - 4
Co-trainers FGDs 1 - - 1 1 3
PHTs IDIs 1 - - 1 2 3
Divisional PHO IDIs 1 - - 1 1 3
Managers IDIs 2 - - 2 - 4
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All interviews were translated into English and tran-
scribed using Microsoft Word. Illustrative words and
phrases were kept in their original language where direct
translation was difficult. The interviewer and recorder
reviewed information from all interviews at the end of
each interview to validate records and to identify new
issues. Where relevant, the latter were incorporated into
discussion guides for subsequent interviews. Analysis
was based on inductive and deductive processes, using a
thematic framework [25]. Themes were modified as
more issues were identified from the data. Two
researchers (YR and VM) jointly conducted the analysis
to strengthen the objectivity of the process. Regular con-
sultations were held with other members of the research
team to enhance reflexivity.
Ethical considerations
The study was reviewed and approved by national scien-
tific steering and ethical review committees in Kenya.
Data collection was planned around local community
timetables and took consideration of events and routine
activities. The research aim and processes were
explained to all participants as appropriate, and their
informed consent was obtained both for participation
and for recording of interviews.
Results
This section presents findings structured around; the
stakeholders’ perceptions of the role of PMRs, the value
and feasibility of programme goals, perceived impact of
the programme, factors influencing programme delivery
and stake holder’s recommendations to improve
implementation.
Stakeholder’s perceptions of the role of PMRs
Across all the sites there was consensus amongst users
on the general role of shops selling OTC medicines
prior to programme implementation. This was described
as provision of “first aid”, or more convenient access to
treatment than expert sources in a range of situations as
illustrated by a mother: “It all depends on the symptoms.
At first I will notice the child coughing, then when you
touch the head you feel the fever and see whether he has
flu so at times like these, I will run to the shop to buy
drugs to check on him for about two days. If I see he is
not getting better then I will go to the hospital”
The expert sources referred to were government and
private hospitals, clinics and dispensaries. Discussions
on the role of general shops referenced relative merits
of alternative providers and assumed lack of technical
knowledge on illness or medicine use among PMRs.
Specific situations were described when hospitals or
clinics were far away or closed (evenings, nights,
weekends), illustrated by a mother saying that:“Some-
times you go to the hospital and miss the doctors so you
run to the shop as you wait for Monday to see a doctor
especially on Sundays.” Retailers are also used when hos-
pitals and clinics do not have medicines available and
when visiting clinics and hospitals will involve the
mother waiting in queues for a long time or facing
harsh staff attitudes as was described by a mother: “I
decided to go to the Government Health Centre where I
spent the whole day without being attended to. So when
I went back home I decided to purchase malaria drugs
from the shops and they got healed. From that experi-
ence I decided that I would never ever go back to that
Health Centre”.
The cost of treatment was widely reported as critical
in decision-making, with PMRs perceived as offering a
more affordable service. PMRs provide commercial ser-
vices but mothers can choose a drug to fit their budgets,
and some PMRs may offer credit to regular customers.
These observations mirror studies conducted in other
settings where PMRs are patronised due to greater phy-
sical proximity compared to health facilities [1,26-29],
where carers perceive an illness to be non severe or
w h e r eo u t l e t sa r et h o u g h tt oh a v eam o r er e l i a b l ed r u g
supply than clinics [1,30,31]. Similarly, their ability to
respond to community demand by selling drugs in
accordance with clients’ needs [32], being friendly, offer-
ing credit to clients and being more affordable than
formal health facilities [27] have also been reported as
reasons for PMR use.
Specialist drugs shops were a prominent feature of the
retail sector in some areas. Earlier surveys in all three dis-
tricts indicated that PMRs trading from “chemist shops”
are found in market centres, particularly in Busia and
Makueni [33]. These are registered under the name of a
trained pharmacist but may not be run on a day-to-day
basis by this individual. However, chemist shops are
licensed to sell a wider range of medicines, and dispense
these from bulk containers at a cheaper price than the
packaged medicines sold in general shops. Many mothers
considered chemist shops to be more reliable sources of
advice and sell better quality medicines than general
shops. The wider choice of medicines, lower prices and
perceived reliability also made chemist shops popular.
This was not a consistent preference, however, since
some mothers were sceptical of chemist shops, recognis-
ing the technical limitations of many of the staff
employed. A mother described that: “In some chemist
shops, friends, relatives or family members end up serving
as attendants. All they do is put on the white coats and
then pretend to be qualified to prescribe drugs”.
General retail outlets were described as having unreli-
able drug stocks in some instances, especially in the
more remote rural outlets, where small shops were
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most commonly lower priced antipyretic medicines such
as paracetamol and aspirin-containing brands. They fre-
quently did not stock antimalarial medicines, as shown
both by local client descriptions and quantitative surveys
[22]. This is exemplified by a mother who explained
that:“Not all shops have the drugs. Here we get Malara-
tab (amodioquine) but in interior places they buy only
cheap drugs like panadol and aspirin. They don’tb u y
highly priced drugs.” Larger shops in market centres
were more reliable sources of antimalarials. Proximity to
a hospital, clinic or chemist also deterred shops from
stocking antimalarial drugs in some cases, due to the
competitive advantage already described for these
providers.
Regarding the interactions between PMRs and clients,
the relationship between them was generally charac-
terised by low trust; illustrated by suspicions about
over-charging, PMRs’ lack of knowledge about health
issues, their perceived eagerness to make any sale and
the quality of the drugs they stocked. Typically, a PMR
described that: “They (clients) had problems in taking
the full dose (of antimalarials). When you tell them to
take three tablets then tomorrow take another three...
then another... they don’t come because they find it hard
and think that you want to steal their money”.
In the absence of any knowledge of the programme,
mothers often reported that their own views of PMRs as
business people would strongly influence them away
from accepting a PMR’s advice about drugs. Thus,
mothers reported feeling suspicious of PMRs’ motives if
they recommended that customers buy medicines other
than those requested. This concern about profit motiva-
tion was reinforced by the experience of different shops
selling the same medicines at different prices. In addi-
tion, prior to the programme, the vast majority of clients
did not consider PMRs to be good advisors on health
issues. PMRs themselves reported reliance on package
instructions, their own experience gained from trial and
error, observations of treatments used in clinics and
mass media advertising for information on use of medi-
cines. Since most medicine packages in Kenya contain
information on active ingredients and doses, less literate
PMRs (and mothers) were felt to be particularly disad-
vantaged by being unable to read package instructions.
For these reasons, and as reported elsewhere [8,34],
choice of OTC medicines was therefore largely demand
driven.
PMRs described the same phenomenon, explaining
that they sell the medicines customers ask for, and
describing customers as being unprepared to consider
alternatives. Both PMRs and their customers often com-
plained about each other’sa t t i t u d e s ,P M R sb e i n g
described as untrustworthy, arrogant and rude and
customers as argumentative and not prepared to listen.
One PMR reported that: “There is a group of customers
who are stubborn to a level that whenever they come to
the shop and order for two Aspirins, two Panadols and
one Action tablet they just expect to get that and no
more questions or instructions. They may even become
abusive if you tried telling them that you feel that they
would better take antimalarial drugs. With such people
we just give them what they ordered for and business
continues”. Mothers also described concerns about the
quality of drugs in general shops and the effect of the
way they are stored and handled on this. Although the
quantitative assessment showed that antimalarial medi-
cines were usually sold within their expiry dates [33], it
was widely felt that PMRs might be selling expired
drugs. There was a special concern reported on unpack-
aged drugs sold loose from tins, where information on
the outside of the tin might not correspond with the
contents. This compounded with the fact that in Kenya,
medicine packs do not contain any indicator of registra-
tion status from the regulatory authority, makes it diffi-
cult to track quality of drugs sold. In addition, mothers
believed that storing drugs in positions where they
would be open to the atmosphere or exposed to dirt,
smoke and sun would affect their quality.
From this description, it emerges clearly that the com-
monly perceived role of PMRs is to provide a pragmatic
solution for clients who are seeking rapid and affordable
treatment for conditions that are not thought to be very
serious, a choice highlighted by dissatisfactions with and
inaccessibility of formal sector providers. Their use is a
result of a deliberate and continuously evaluated balance
of choice between different potential treatment sources.
Major reservations with PMR services concerned their
commercial orientation and la c ko fe x p e r t i s ei nh e a l t h
care (from clients) and their unregulated and fluid nat-
ure (from trainers and managers). These factors have a
major influence on the relationship between PMRs and
their clients and potential trainers, which in turn forms
the backdrop to any intervention targeting behaviours of
these key actors.
Value and feasibility of programme goals
Across all groups, actors supported programme goals.
Amongst the mothers who participated in FGDs, aware-
n e s so ft h ep r o g r a m m ef o l l o w e dt h es a m ep a t t e r n sa s
the intensity of public information and PMR training,
with greater awareness in those areas where more activ-
ities had taken place. However, while largely expressing
support for the programme goals, many mothers
expressed reservations about feasibility. A strong senti-
ment concerned the influence of the personality and
attitude of individual PMRs, thus: “It depends on a
person’s attitude ....there are people who may have a
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you while others will have a positive attitude and are
committed regardless of any other issues like time”.
Direct experience and prior awareness of the pro-
gramme appeared to affect the way that mothers
discussed both the sector and the programme. Positive
ideas about retailers and fewer reservations about the
feasibility of change were expressed in the groups with
prior awareness or direct experience of interacting with
a trained PMR. This change in attitude - and its cause -
was also illustrated by a PMR saying that:“The seminar
was good because I had difficulty telling people about it
but (later) they would come and tell me, ‘we have heard
that you were trained on how to use antimalarial drugs,
now I need them“. Programme materials were consid-
ered particularly important by PMRs, who frequently
described programme drug dosage charts and posters as
acting as “certification” for the training. PMRs described
some additional factors they believed promoted change
as age, with younger customers showing more flexibility,
and customers’ previous experiences with drug advice
from trained PMRs. Mothers’ support for the pro-
gramme goals was described in terms of improving the
health of the community; reducing malaria; improving
the way that retailers sell and advise about drugs;
improving knowledge of the community about OTC
medicines; using OTC medicines better; improving
access to treatment; and saving money by using correct
medicines in the right way.
T r a i n e dP M R se x p r e s s e dc l e a ra n ds u p p o r t i v ei d e a s
about the rationale for the programme around improv-
ing quality of care given: “The organizers realized that
some community members treat malaria by taking the
wrong dose. They also buy drugs from shops that could
be poisonous to them. So they found it better to train the
PMRs so as they can train others on how well to use the
drugs"; information on new drug policy changes “We
were taught so that we can move with the times and not
just continue with sulphadoxine pyrimethamine (SPs) yet
the drug at the moment is amodiaquine"; and knowledge
on malaria danger signs: “They felt the ones that are ser-
ious or have danger signs should go to the hospital and
the ones with minor symptoms to be treated in the
shops.”
Given their profit orientation, it was important for
implementation that a majority of PMRs felt that they
had benefitted financially from participation. The key
content issue that was raised concerned the antimalarial
medicine promoted through the programme, including
confidence in the programme drug, confusion over its
identification and use and concerns about unexpected
adverse events. A major contributor to these concerns
was the delay and confusion at national and district
levels in identifying the most appropriate OTC
antimalarial medicine, given that these programmes
were initially rolled out at a time of national antimalarial
drug policy change. An interval of over one year elapsed
before beginning sensitisation for this programme within
districts and eventual rolling out to PMRs. The drug
that was finally identified, amodioquine, had been avail-
able in private retail outlets for some time, and was not
therefore a new medicine. However, a total of 12 brands
of amodioquine were found in shops in each district,
making it difficult to identify which antimalarial medi-
cines were amodioquine. In this commercial market,
promotional materials could not be developed for speci-
fic brands and there was no policy on over-branding to
support product recognition. This led to difficulties for
trainers, PMRs and their clients in consistently identify-
ing amodioquine medicines at retail outlets. Confusion
over brand names, regulatory infringement and poor
quality drugs have been concerns for the inclusion of
the retail sector in malaria control in other settings
[13,19,32]. The quantitative surveys in this programme
evaluation [22] also pointed to confusion between differ-
ent types of antimalarial brands. Overall, the number of
brand names in the market continued to challenge the
familiarity of both PMRs and their clients on the nation-
ally recommended antimalarial medicines especially
during this transition period of drug policy changes.
Discussions with many PMRs illustrated that they are
often challenged by the conflict between profit motiva-
tion and a real desire to offer a good service to the com-
munity. This may reflect the fact that the study was
largely conducted in rural areas, where PMRs would
often be neighbours or relatives of many of their clients.
An interesting aspect of this relationship was the prac-
tice of offering credit to some clients as a coping strat-
egy to increase demand for high cost of antimalarials.
PMRs often discussed providing credit as a practice car-
rying high risks which they preferred to avoid unless
customers were well known and had a good track
record of repaying debts. Their more likely response to
a mother with insufficient funds would be to recom-
mend alternative medicines. However some found it
morally difficult to sell medicines that they knew - after
the training - were relatively ineffective, saying for
example: “There’s a negative experience. When someone
c o m e st ob u yS P ,If i n di th a r dt os e l lt oh i m .S ot h e
stock is still there and that’sal o s st om e ”.O t h e r s
described that they would provide credit to less well-
known customers in extreme circumstances, for exam-
ple serious illnesses or where there is no means of
travelling to a clinic. One PMR described losing money
through credit as inevitable, saying that: “One customer
will come and say ‘Ia ms i c ka n dId o n ’t have a shilling’
so you give out drugs on credit then he brings you the
money later so you help one another. But for others
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he will run away and never come back, and when he
gets money he runs to another shop”.
Perceived impact of programme
A summary of the perceived impact of the programme
and moderating factors are presented in table 2. All
groups reported improved knowledge and practices on
the use of OTC antimalarial medicines as a result of the
programme. PMRs consistently reported improvements
on giving advice to customers on medicine use. This
was often confirmed by mothers and trainers, particu-
larly in the district with intensive implementation. Other
changes described by PMRs were referring clients who
were very ill to hospital; not selling medicines to very
young children; knowing how to treat own family mem-
bers; selling more medicines; getting more customers
and making more profits. For example, PMRs that
already stocked antimalarials were sometimes able to
persuade clients to buy full courses rather than single
doses. This led to reported financial benefits attributed
to increased turnover of drug stock due to selling full
instead of partial courses as illustrated by a retailer:
“Our profits depend on how drugs move... before you
could sell one box per month but now you sell 3 boxes in
a month. If for one box you get a profit of 50 shillings in
a month you will have 150 shillings”.S o m et r a i n e d
PMRs reported savings through greater efficiency in
stocking antimalarial and antipyretic drugs as a result of
increased understanding of the differences and similari-
ties between them. In addition some reported improved
status and relationships with customers.
Another perceived impact was the improved relation-
ship between PMRs and their regulators especially in
the district with highest levels of implementation. Their
roles had reportedly led in the past to tensions between
PHOs and PMRs. However, many PMRs spoke in posi-
tive terms about their trainers’ skills and attitudes
Table 2 Summary of reported impacts, and perceptions of moderating factors
Reported impacts Moderating factors
ON COMMUNITY:
Positive attitudes/better relationship with PMRs
Improved use of OTC medicines/some report no change*
More likely to accept advice from PMRs
Experienced better outcomes from treatment
Positive:
Knowledge of programme (through public information or direct experience)
Availability of programme materials (act as validation of training)
Shopkeeper’s knowledge, attitude and communication skills
Availability of credit
Negative:
High cost of drugs
Lack of familiarity with drugs/preferences
Side effects of drug
Inability to read instructions
Time taken in buying drugs from trained retailers
Use of proxy customers
Rapid improvements in symptoms
Contradictory messages on packaging and mass media (e.g. radio advertisements)
ON PMRs:
More knowledge about malaria and its treatment
More likely to ask customers questions, give advice on
drug use and refer to hospital
Financial gains from selling more drugs and getting more
customers
Financial losses if not able to sell
Improved status in community
Better relations with community and public health
officers
Less likely to sell expired drugs†
Positive:
Exposure to training
Materials: support training and validate trained PMRs
Public information activities (where held)
Shopkeeper’s attitude positive
Customers’ attitude positive
High coverage of shops in surrounding area
Negative:
Cost of drugs
Instability of some shops and staff in shops
Proximity to hospitals, clinics and chemists (don’t stock antimalarials because cannot
compete on prices)
Situated in remote rural areas: often small outlets, do not stock antimalarials because
expensive to stock and low turnover
Time taken in training and advising
ON TRAINERS AND MANAGERS (Busia and Makueni‡)
More knowledge and skills on malaria control, training
and programme management
Improved status for trainers in community and with PMRs
Better relationship between PHOs and PMRs
PHOs supported to conduct other routine activities
Trainers feel positive - bringing about change and getting
positive feedback from PMRs
Positive:
Positive attitudes in DHMT
Technical support from KEMRI
Negative:
Inadequate resources such as coverage of programme, unable to undertake monitoring
and public information activities, low allowances to co-trainers, materials not adapted to
current drug policy
Delays in disbursement of funds
* No change especially reported by mothers in Kwale
† This perception was reported by mothers
‡ Trainers and managers not interviewed in Kwale
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monitoring visits and described feeling free to ask ques-
tions. This suggests the potential for an outcome of
improved relationships, resulting in PHOs having
greater influence and more opportunities to further
strengthen PMRs’ practices. This would be of particular
importance during drug policy change, including the
introduction of artemsinin combination therapy (ACT)
in this sector. It may also support greater involvement
of PMRs in other public health programmes with
impacts beyond the selling of antimalarial drugs. Of
importance for sustainability, involvement in the pro-
gramme and observation of an impact of their efforts
were valued by many trainers, particularly in the district
with highest levels of implementation and PMR behavior
change. For example, one such trainer reported: “Iw a s
pleased because there is a place I had gone to visit shops
and there was a mother who was being sold drugs for a
child. The seller asked her questions and I found that
really what I had trained was being followed. I felt
happy”.
Factors influencing programme delivery
The barriers and facilitating factors for changes were
reported consistently across all districts by all actors. A
majority of mothers reported that the main drive to
change at community level was knowledge of the pro-
gramme itself, through public awareness activities and
through direct contact with trained PMRs and pro-
gramme materials. Most PMRs on the other hand per-
ceived the training itself as the main factor facilitating
their own change, strongly supported by monitoring and
public information activities and programme materials.
Positive attitudes and support from DHMT were
reported as important factors supporting change within
the training teams, but trainers and managers generally
discussed a lack of resources to fully implement pro-
gramme activities as a major limitation. For some trai-
ners and most co-trainers, this primarily concerned the
lack of allowances for transport and undertaking train-
ing or monitoring activities. For the managers, the main
budgetary limitations were in supporting adequate pub-
lic information and monitoring for the programme,
where these were seen as key to change for trainers,
PMRs and their customers.
Several factors were widely discussed by mothers, trai-
ners and managers as major barriers for change. For
example, the time taken for a trained PMR to ask ques-
tions and offer advice reportedly dissuaded customers
from using the outlets either for their own drug pur-
chases or while they waited for others to do the same.
In Busia, managers described an additional challenge as
the relative instability of shops and trained personnel
within shops. Their experiences had shown that many
shops open and close repeatedly over time, depending
on their economic circumstances and availability of per-
sonnel. Many employees in shops had a rapid turnover
as they moved on to better paid jobs. This emphasised
the need for repeated training and for staff to be able to
conduct on-the-spot training during monitoring visits.
Regarding the training itself, the direct and indirect
costs of attending workshops and stocking recom-
mended drugs were important barriers. Attending work-
shops could involve losses due to closing an outlet
during training and spending cash on transport to the
training venue. These were immediate challenges for
families relying on petty trading to buy food and other
essentials on a daily basis. In practice, the turnout of
PMRs at workshops was relatively good with over 80%
of invited PMRs attending training and with a consistent
pattern of increasing turnout as the programme became
more established in all districts. However, despite some
PMRs reporting increased turnover of drugs (as was
mentioned earlier on) others, especially those who did
not regularly stock antimalarial medicines prior to train-
ing, found it difficult to afford them in the same way
that their customers reported difficulty in purchasing
these. Since their practices are largely led by consumer
demand, and as their small-scale businesses generally
operate on low profit margins, they tended generally to
stock goods with a rapid turnover. Overall, PMRs faced
challenges in selling drugs especially the expensive
drugs a problem particularly faced by those in remote
rural areas and those near to clinics, pharmacies and
hospitals.
Factors that limited the likelihood of customers buy-
ing amodiaquine in full doses tended to deter PMRs
from stocking and recommending them. This includes
both the cost and any perceived side effects of the
drugs. A particular cost disincentive was experienced
by one group of PMRs in Makueni who reported that
they had stocked amodiaquine drugs after the training
but had been unable to compete with the lower prices
(and perceived greater reliability) of the nearby chemist
and hospital, leading to unsold stock. In all districts,
some retailers reported being unable to afford to stock
amodioquine, and these individuals did not perceive
financial gains from the training. Where sellers felt
unable to benefit financially from the training, they
were much more likely to complain about the costs of
participating in the programme and to demand bene-
fits, such as better compensation for their time during
training or the provision of starter packs of drugs.
Where sellers described increased profitability of their
businesses in the longer term as a result of the train-
ing, this seemed to provide significant compensation
for any losses incurred during the workshop in all
districts.
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oped by the DoMC [35], and provided to trained PMRs
as a reference material for the programme, produced a
practical anomaly given the manufacturers’“ blister
pack” packaging style and instructions for this drug. Fol-
lowing DoMC recommendations meant that clients
would always have to purchase more pre-packed amo-
diaquine than the recommended dose at every age.
PMRs were advised to recommend that their clients dis-
pose of left-over portions of tablets, which could be up
to one and a half tablets for a full adult course. This
was an unpopular recommendation for families buying
expensive medicines and experiencing frequent episodes
of fever. In addition, most manufacturers recommended
a different dosage to the government recommended
regime, an observation that was reported as leading to
confusion amongst both PMRs and their customers.
Some trainers described being confused by hearing con-
tradictory drug dosage messages as part of radio adver-
tisements promoting SP drugs. Finally, some actors
described side effects of amodiaquine as being barriers
to their use, and where this occurred the experience
could be marked.
All trainers described frustrations concerning
rumoured expectations of benefits during programme
implementation. For example, many co-trainers became
frustrated when expected benefits, such as reimburse-
ment for time spent outside the workshop and provision
of bicycles to support travel, did not materialise. The
allowances paid during the workshop were also generally
considered inadequate, especially for those who had to
remain away from home overnight. In both Makueni
and Busia, confusion about allowances led to rumours
that the funds originally allocated to them were being
used for other purposes. Similarly, some co-trainers had
questions about the accounting system for allowances
paid during the workshops. Some believed that they had
not been sufficiently consulted in planning the trainings,
giving an example of being informed last minute about
workshops. One group described their “powerlessness”
to act in support of perceived problems, fearing that
they would not be retained within the programme.
These frustrations and lack of support for transport
undermined co-trainers ability to participate actively in
the programme. These issues illustrate some of the diffi-
culties associated with programmes incorporating com-
munity “volunteers” described in other settings [36]. In
this programme, these difficulties were accentuated by
unmet expectations arising from lack of clarity about
tasks, roles and availability of re-imbursement. The
choice of personnel was important. Interviews with
volunteer co-trainers in the district where selection was
made by the local community suggested that they
accepted the volunteer role and reported higher levels of
job satisfaction than in districts where chiefs were lar-
gely responsible for the appointment. This observation
concurs with recommendations that interventions with
wider buy-in are likely to be more successful [19].
Stakeholder recommendations to improve
implementation
Strong central support emerged as a critical issue in all
districts. All stakeholders expressed opinions on areas
where more national level strategic support was needed,
including the overall approach of working with medicine
retailers, national coordination of information on medi-
cine use, provision of adequate programme resources
and tackling affordability issues.
The selection process for PMRs in this programme
was a challenging aspect of implementation with both
positive and negative outcomes perceived for any given
strategy across actors. In principle, the programmes
aimed to train all retailers selling antimalarial drugs,
but, in practice, this proved a very difficult criterion to
d e f i n e .O n ei s s u ew a st h ec h a n g e a b l en a t u r eo fd r u g
stocking practices, with fluctuations being largely depen-
dent on the PMR’s current financial status; small rural
shops being particularly vulnerable to this effect. In any
case, the large numbers of such outlets made it difficult
for managers to collect accurate information on shop
status, including drugs stocked, at any given time. In
this study, there was no consensus amongst stakeholders
on which shops should be included in the programme.
Discussion
This paper has illustrated the importance of understand-
ing factors underlying implementation in assessing PMR,
and other, programme impacts. The data corroborates
quantitative outcomes and provides a deeper under-
standing of some of the potential influences over effec-
tiveness of these MoH interventions. It emerges from
this evaluation that the proposed role for PMRs in
malaria control, of acting as advisors and promoting a
public health good, is in conflict both with their normal
practices and with mothers’ perceptions of their under-
lying motivations. The qualitative findings are complex;
some point to the feasibility of change, and others at
significant barriers requiring programme modification
before either retailer or community OTC medicine use
can improve on a wide scale.
One potential limitation in interpreting this data is the
positionality of the researchers (from KEMRI), since this
organization was often perceived as having played a sig-
nificant role in the supporting with MoH in designing
the programme activities. There may therefore have
been a tendency for some interviewees, particularly dis-
trict managers and trainers, to focus more on positive
than negative aspects of the programme. To counter
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and non-judgmental atmosphere for the discussions and
explained the importance of being open about views so
that we could learn from their experiences. The second
limitation regards period of evaluation (6-8 months post
implementation), making it difficult to assess the likeli-
hood that the positive impact of the intervention would
be maintained over time. This is also compounded by
the fact that there were limited supportive supervisory
activities conducted.
Barriers and facilitating factors for programmes
Some findings underline described barriers to change in
PMR programmes, including the resources needed
within over-stretched government health services to
train and monitor large numbers of largely unregulated
medicine sellers [8,10,37], the relative instability of out-
lets, medicines stocked and retail personnel [9], the
large number of proprietary brands, the substandard
quality of some OTC medicines [10,38], and the wide
availability of counterfeit medicines. Further important
challenges to emerge from this study are the lack of
trust of customers towards PMRs; the resulting reluc-
tance to accept advice to buy a different, more expensive
medicines; and the economic challenges to retailers in
stocking antimalarial medicines, as well as to their cus-
tomers in buying them. At a more central level, the
study strongly emphasises the need for unambiguous
support and a broad range of national strategies to
strengthen the feasibility of change in community use of
OTC antimalarials [8,39,40], including: provision of a
clear drug policy for the sector; central coordination of
drug use information; adequate drug quality control;
and strategies to support economic access to full courses
of antimalarial medicines.
Despite these challenges, there are several findings
that support the feasibility of such programmes promot-
ing change. As a fundamental starting point, all stake-
holders perceived the programme goals to be valuable.
Furthermore, given the commercial nature of a retailer’s
role, it is crucial that the majority of retailers reported
positively on the programme’si m p a c to nt h e i rb u s i -
nesses, describing increased customer satisfaction, more
customers, more rational purchasing of medicine stock
and increased medicine sales. The overall improvement
in the relationship between retailers and their clients
that was described by some may also be important to
counter the mutual mistrust that commonly charac-
terises their normal relationship. It is of interest that
improvements in the relationship, and increased confi-
dence amongst retailers about the medicines they sell,
may encourage retailers to extend credit facilities to
their customers. This could be an important step in sup-
porting better access to effective malaria treatment for
the poorest community members. Customers with
experience of buying medicines from a trained retailer
reported markedly better attitudes towards the sector
than those without, although still recommending greater
community involvement in such programmes. This
would suggest that over time, if the programme is suc-
cessful, peoples’ concerns about shopkeeper attitudes
might diminish. This conclusion is supported by the
increased programme impact and more strongly positive
stakeholder perceptions for the programme in the dis-
trict with highest levels of implementation. But many of
the comments made by mothers illustrate that this had
already begun to happen to some extent in all districts.
This strongly supports ideas that measures that build
trust in trained PMRs from the outset are critical factors
for success. This is perhaps the most important area
that programmes currently do not address; that is, the
relationship between medicine sellers and their clients,
and the need to build trust between these groups, for
example, by greater community involvement, public
information and monitoring activities.
Which types of outlets should be included in PMR
training programmes?
Criteria for selection of PMRs for the programmes were
a debated issue amongst stakeholders, with advantages
and disadvantages described across three main different
approaches: targeting all outlets, targeting outlets selling
antimalarial medicines and targeting highly used outlets.
The first approach was mainly recommended by retai-
lers who were clear that as many shops should be
included as possible to reduce the chance that custo-
mers would use non programme shops and therefore
reduce any potential competition between trained and
untrained PMRs. In addition, their descriptions of prac-
tices within the sector made it clear that outlets cannot
be easily separated into those that stock antimalarial
drugs and those that do not as this often varies, espe-
cially in the smaller more rural outlets. Mothers strongly
supported the second approach of training all outlets
selling antimalarial medicines, based on their interest in
a broad regulatory function for training. Some managers
and trainers identified the third approach as a pragmatic
way of maximising efficient use of resources by targeting
fewer, larger, busy shops selling antimalarials in market
centres. Others supported PMRs’ concerns that selecting
specific shops could create conflict between trained and
untrained retailers.
These three selection approaches can be seen to fit
with different strategic models for drug retailer pro-
grammes [7,41]. Targeting all outlets selling medicines
is clearly a huge task, and unlikely to be manageable
within the MoH using a participatory training and mon-
itoring approach as represented by this programme.
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this through mass communication and social marketing
approaches [14,42]. By ensuring an informed public,
mass communication approaches may enable customers
to directly regulate or at least check on sellers’ activities.
The model of targeting highly used outlets selling anti-
malarials leaves many opportunities for community
members to purchase medicines from non-programme
shops. Not surprisingly, retailers were wary of this
model. A highly selected, small group of trained outlets
a r eo n l yl i k e l yt oh a v eab r o a di m p a c to nc o m m u n i t y
drug use if these shops are very strongly promoted and
given a competitive edge, with implications for the level
of monitoring needed to ensure that an adequate quality
of care is given. This approach is close to a social fran-
chising model, involving a closely regulated relationship
between the MoH (franchisor) and outlets (franchisees)
with widely promoted subsidised products. In the social
franchise model, the MoH would take responsibility for
protecting the community from potential manipulation
for profit by highly trained retailers. This type of model
has been suggested for shops as a potential strategy for
distributing newer, more expensive and complex anti-
malarials (ACTs) alongside rapid diagnostic testing [43].
It is also currently being implemented in Kenya for
community health worker outlets and in Tanzania for a
subgroup of shops registered to sell antimalarials [44].
The middle approach, supported by mothers and some
trainers, targets as many shops selling antimalarials as
possible. Given the inevitable resource limitations for
monitoring and the need to address the relationship of
mistrust between sellers and their customers, investing
in public information could support the over-stretched
government regulatory systems and track local contex-
tual issues for the programme. This approach requires
that resources are shared more evenly between training
retailers and strengthening community involvement,
maintaining a balance of knowledge, and therefore
power, between them. The programmes evaluated in
this study lie close to this latter approach, with potential
for greatly increasing impact and sustainability by
strengthening the role of the local community in plan-
ning and monitoring activities.
Can PMR training programmes generally promote better
use of OTC antimalarials?
The main rationale for optimising PMR practices within
a malaria control strategy lies in the increased geo-
graphic (and therefore, indirectly economic) access that
shops provide in rural areas. However, these findings
point to a paradox for access and availability of OTC
antimalarial medicines since it appears that areas with
the greatest challenges in accessing these medicines
(that is, remote rural areas) are also the ones served by
outlets that are least likely to stock antimalarial medi-
cines. This reportedly occurs because neither the PMRs
nor their customers can afford to buy these relatively
expensive drugs. This finding is consistent with other
reports on drugs stocked in private retail outlets [9,10].
Some outlets in rural areas also experienced a similar
economic challenge in stocking antimalarial medicines
since they were in direct competition with either
chemists selling loose tablets at a lower price or clinics
offering subsidized services. Many retail outlets were
therefore unable to make the switch to stocking antima-
larial medicines, both because they cannot afford to pur-
chase the stock and because their clients cannot afford
to provide a regular demand for them. Such observa-
tions provide further evidence for the need to provide
subsidies in the private retail sector for expensive medi-
cines, and will be of critical importance in the introduc-
tion of ACTs to peripheral level distributors [44].
Conclusions
This study describes the experiences, perceptions and
attitudes of stakeholders in three PMR training pro-
grammes in different districts in Kenya. The findings
were similar across districts, but with important addi-
tional supportive findings from stakeholders in one dis-
trict where greater levels of implementation occurred.
The findings show that stakeholders were generally sup-
portive of programme goals but that the proposed role
for PMRs, of acting as advisors and promoting a public
health good, was generally in conflict both with their
normal practices and with mothers’ perceptions of their
underlying motivations. Some findings point to the fea-
sibility of change and others at significant barriers
requiring programme modification before either retailer
or community OTC medicine use can improve on a
wide scale. Understanding the context and implementa-
tion processes of PMR programmes and the perspectives
of key actors are critical to identifying measures to sup-
port their effective implementation. In practice, most
PMRs described increased customer satisfaction, more
customers, more rational purchasing of medicine stock
and increased medicine sales after participation. Public
information can strengthen PMR training programmes
by engaging local communities and may facilitate perfor-
mance monitoring of PMRs by their clients. Factors
undermining programme implementation included a
perceived lack of central support for the approach, lack
of MoH resources to train and monitor large numbers
of PMRs, the relative instability of outlets, medicines
stocked and retail personnel, the large number of pro-
prietary brands and financial challenges to retailers in
stocking antimalarial medicines, as well as to their cus-
tomers in buying them. Financial barriers underlie many
described challenges, with important implications for
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exposure to programme activities promoted trust and
improved relationships between PMRs and their clients
and trainers, strengthening the feasibility of such
interventions.
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